Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.54 USD
Change Today +0.03 / 0.85%
Volume 703.0K
ONTY On Other Exchanges
As of 8:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Diana F. Hausman M.D.

Chief Medical Officer, Oncothyreon Inc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Dr. Diana Hausman, M.D. has been the Chief Medical Officer at Oncothyreon Inc. since January 5, 2012 and served as its Vice President of Clinical Development from August 2009 to January 2012. Dr. Hausman is responsible for planning and implementing the clinical development program for Oncothyreon's pipeline of oncology product candidates. She is an experienced oncologist with an extensive background in drug development. Dr. Hausman joined Oncothyreon from Zymogenetics, ...

Read Full Background

Corporate Headquarters*

2601 Fourth Avenue
Seattle, Washington 98121

United States

Phone: 206-801-2100
Fax: 206-801-2101

Board Members Memberships*

There is no Board Members Memberships data available.


Princeton University
Unknown/Other Education
University of Washington
The University of Pennsylvania

Other Affiliations*

Annual Compensation*

Total Annual Compensation$355,000

Stock Options*

All Other Compensation$10,268
Exercisable Options230,000
Exercisable Options Value$6,000
Unexercisable Options300,000
Unexercisable Options Value$39,000
Total Value of Options$45,000
Total Number of Options530,000

Total Compensation*

Total Annual Cash Compensation$489,693
Total Short Term Compensation$355,000
Other Long Term Compensation$10,268
Total Calculated Compensation$669,693
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ONTY:US $3.54 USD +0.03


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOTHYREON INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at